Hengrui Pharmaceutical announced that the company will hold its first extraordinary shareholders' meeting in 2026 on September 24, 2026 to consider matters including the proposed adoption of the 2026 H share plan. In order to determine the list of H share shareholders entitled to attend the shareholders' meeting, the company will suspend H share transfer registration from September 21 to September 24, 2026. There will be no H share transfer registration procedures during this period. The record date is September 24, 2026. H share shareholders who wish to attend and vote must submit the transfer documents and related shares to the H share transfer registration office before 4:30 p.m. on September 18, 2026 to complete registration.

Hengrui Pharmaceutical announced that the company will hold its first extraordinary shareholders' meeting in 2026 on September 24, 2026 to consider matters including the proposed adoption of the 2026 H share plan. In order to determine the list of H share shareholders entitled to attend the shareholders' meeting, the company will suspend H share transfer registration from September 21 to September 24, 2026. There will be no H share transfer registration procedures during this period. The record date is September 24, 2026. H share shareholders who wish to attend and vote must submit the transfer documents and related shares to the H share transfer registration office before 4:30 p.m. on September 18, 2026 to complete registration.